InvestorsHub Logo

Wolf-man jack

08/07/19 8:50 AM

#53662 RE: vhgier #53657

Dr. V. Mona And CVSI about the Options scenario. From the Q1 .,5 year plan.

https://www.sec.gov/Archives/edgar/data/1510964/000151096419000027/0001510964-19-000027-index.htm

The Company recognized stock-based compensation expense of $9.9 million and $1.0 million in its operating income (loss) for the three months ended March 31, 2019 and 2018, respectively. During the three months ended March 31, 2019, the former President and Chief Executive Officer ("Mona") and the Company entered into a Settlement Agreement (the “Settlement Agreement”), pursuant to which the Company agreed that Mona’s resignation from the Company on January 22, 2019 was for Good Reason (as defined in Mona’s Employment Agreement) and agreed to extend the deadline for Mona’s exercise of his stock options for a period of five years. In exchange, Mona agreed that notwithstanding the terms of his Employment Agreement providing for acceleration of vesting of all stock options and restricted stock units (RSU's) upon a Good Reason resignation, certain of his unvested stock options would not immediately vest, but rather continue to vest if, and only if, certain Company milestones are achieved related to the Company’s drug development efforts. These stock options were issued in July 2016 (6,000,000 options) and March 2017 (5,000,000 options). The Company and Mona also agreed to mutually release all claims arising out of and related to Mona’s